Stem-Loop Primer Design for Mutant Nucleic Acid Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for detecting mutant sequences using template-specific probe amplification, such as qPCR, suffer from a lack of specificity when distinguishing between mutant and wild-type sequences, particularly in the presence of wild-type sequences without the mutation.

Innovation Solution

The use of stem-loop primers with specific configurations, including 5′ hemiprobe, stem-loop, and 3′ hemiprobe sequences, that preferentially amplify mutant polynucleotide sequences over wild-type sequences, along with reverse and forward primers, to enhance selectivity in detection.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If template-specific probe amplification methods (qPCR) are used for mutant sequence detection, then the detection capability is provided, but the specificity for distinguishing mutant sequences from wild-type sequences deteriorates

Engineering Contradiction:
Improvespecificity of mutant sequence detectionVSAvoidaccuracy in distinguishing mutant from wild-type sequences
Core Design Contradiction:
Measurement precisionVSReliability

Solution Approach 1:

The primer design incorporates local quality differentiation through the 3′ terminal nucleotide that is complementary to the mismatch (mutant sequence) but not to the wild-type sequence. This local modification at the 3′ end of the primer creates selective binding affinity: the primer can extend on mutant templates but is blocked on wild-type templates, thereby resolving the contradiction between detection capability and specificity.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The invention changes the chemical parameter of the primer sequence by incorporating a specific nucleotide at the 3′ terminal position that matches the mutant sequence but mismatches the wild-type sequence. This parameter change in primer composition creates differential binding thermodynamics, allowing selective amplification of mutant sequences while preventing wild-type amplification, thus improving both measurement precision and reliability.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If conventional PCR primers are used, then amplification of both mutant and wild-type sequences occurs, but the selectivity for mutant sequence detection deteriorates

Engineering Contradiction:
Improveamplification efficiencyVSAvoidselectivity for mutant sequences
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The primer incorporates local quality differentiation at the 3′ terminal nucleotide position, which is complementary to the mutant sequence mismatch but not to the wild-type sequence. This local modification enables the primer to maintain amplification efficiency on mutant templates while selectively blocking amplification on wild-type templates, thereby resolving the contradiction between productivity and measurement precision.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

Instead of designing primers that amplify both sequences and then distinguishing them post-amplification, the invention inverts the approach by designing the primer to selectively amplify only the mutant sequence from the beginning. The 3′ terminal nucleotide is specifically configured to match the mutant mismatch, creating inherent selectivity in the amplification process itself rather than relying on subsequent detection steps.

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach significantly improves the selectivity of mutant sequence detection, allowing for accurate differentiation between mutant and wild-type sequences, even at low mutant-to-wild-type ratios, as demonstrated by the ability to detect mutant sequences in various clinical and diagnostic applications.

Implementation Method 1

a 5′ hemiprobe sequence configured to hybridize to a complementary first end region of the DNA sequence; a 3′ hemiprobe sequence configured to hybridize to a second end region of the DNA sequence

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

incubating the reaction mixture under conditions suitable to extend a product containing the 3′ hemiprobe sequence

Methodology Applied
Scientific EffectDNA polymerization:

Data Source

PatentUS20240368688A1Methods and compositions for detection of mutant nucleic acid sequences
Publication Date: 2024.11.07 TATAA BIOCENT
  • US20240368688A1 patent drawing
  • US20240368688A1 patent drawing
  • US20240368688A1 patent drawing

AI summary

Described herein are methods and compositions for detection of mutant nucleic acid sequences. In some cases, the methods and compositions used herein utilize a two-tailed primer in combination with one or more forward and reverse primers configured to hybridize to particular regions of the two-tailed primer to enable detection of a mutant sequence with high selectivity.